Wednesday, Aug 12, 2020 | Last Update : 12:50 PM IST

140th Day Of Lockdown

Maharashtra53560136843518306 Tamil Nadu3086492506805159 Andhra Pradesh2445491547492203 Karnataka1886111055993398 Delhi1461341316574131 Uttar Pradesh126722767212120 West Bengal98459671202059 Bihar8274154139450 Telangana8075157586637 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3433121832109 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
  Technology   Mobiles & Tabs  16 Jun 2020  How about letting your child play a videogame to help with ADHD?

How about letting your child play a videogame to help with ADHD?

AFP
Published : Jun 16, 2020, 9:20 pm IST
Updated : Jun 16, 2020, 9:20 pm IST

A videogame called EndeavorRx has been approved by the USFDA for children aged 8-12 who have been diagnosed with ADHD.

The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)
 The USFDA said EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD and is the first game-based therapeutic approved for any type of condition. (Photo | Screengrab)

Washington: US health officials have approved the first game-based treatment for children with attention deficit hyperactivity disorder, part of a trend toward “digital therapeutics” or software to address certain conditions.

The Food and Drug Administration said Monday it approved the sale by prescription of the game EndeavorRX from health tech startup Akili Interactive for children aged 8-12 who have been diagnosed with ADHD.

 

The FDA said this was the first digital therapeutic intended to treat ADHD, as well as the first game-based therapeutic approved for any type of condition.

The game, designed to improve cognitive function, is designed as part of a programme that may also include other kinds of therapy, medication, and educational programs.

“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren, director of the FDA Center for Devices and Radiological Health.

Digital therapeutics have been approved for certain treatments such as addiction disorders and are being testing for a range of other conditions from chronic pain to anxiety.

 

EndeavorRX allows children to control cartoon-like characters on a type of hoverboard and is designed to target and activate neural systems through sensory stimuli and motor challenges to improve cognitive functioning.

“We’re proud to make history today with FDA’s decision,” said Eddie Martucci, chief executive officer of Akili.

“With EndeavorRx, we’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.”

The approval of EndeavorRx followed studies of some 600 children diagnosed with ADHD.

The company said the research found that after four weeks of EndeavorRx treatment, one-third of children no longer had a measurable attention deficit on at least one measure of objective attention and that about half of parents saw a meaningful change in their child’s day-to-day impairments after one month of treatment with EndeavorRx.

 

Tags: videogames, adhd, usfda